1. Volume 65, Issue 2, Pages 499-509 (February 2004)
5-Aminoisoquinolinone reduces renal injury and dysfunction caused by experimental ischemia/reperfusion 
Prabal K. Chatterjee, Bristi E. Chatterjee, Helene Pedersen, Ahila Sivarajah, Michelle C. McDonald, Helder Mota-Filipe, Paul A.J. Brown, Keith N. Stewart, Salvatore Cuzzocrea, Michael D. Threadgill, Christoph Thiemermann 
Kidney International 
Volume 65, Issue 2, Pages (February 2004)
DOI: /j x
Copyright © 2004 International Society of Nephrology Terms and Conditions

2. Figure 1
Effect of 5-aminoisoquinolinone (5-AIQ) (0.01 to 1mmol/L)(N = 12)on the increase in poly (ADP-ribose) (PARP) activity caused by hydrogen peroxide (H2O2) (1mmol/L for 1hour)(N = 12)in rat proximal tubular cells. 5-AIQ causes a concentration-dependent attenuation of the increase in PARP activity caused by H2O2. Data are expressed as mean ± SE mean of N observations. ⋆P < 0.05 when compared with H2O2 only; ▪P < 0.05 when compared with control proximal tubular cells (untreated cells).
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

3. Figure 2
Effect of 5-aminoisoquinolinone (5-AIQ) (0.01 to 1mmol/L) (N = 12) on the impairment in mitochondrial respiration (MTT assay) caused by hydrogen peroxide (H2O2) (1mmol/L for 4hours) (N = 12) in rat proximal tubular cells. 5-AIQ causes a concentration-dependent attenuation of the impairment in mitochondrial respiration caused by H2O2. Data are expressed as mean ± SE mean of N observations. ⋆P < 0.05 when compared with proximal tubular cells treated with H2O2 only.
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

4. Figure 3
Effect of 5-aminoisoquinolinone (5-AIQ) (0.01 to 1mmol/L) (N = 12) on the release of lactate dehydrogenase (LDH) from rat proximal tubular cells caused by hydrogen peroxide (H2O2) (1mmol/L for 4hours) (N = 12). 5-AIQ causes a concentration-dependent reduction of LDH release caused by H2O2. Data are expressed as mean±SE mean of N observations. ⋆P < 0.05 when compared with proximal tubular cells treated with H2O2 only; ▪P < 0.05 when compared with control proximal tubular cells (untreated cells).
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

5. Figure 4
Effect of 5-aminoisoquinolinone (5-AIQ) on alterations in serum levels of creatinine (glomerular dysfunction). Rats were subjected to the surgical procedure alone and treated with saline (sham + saline, N = 10) or 0.3mg/kg 5-AIQ (sham + 5-AIQ, 0.3mg/kg intravenous bolus 5 minutes prior to reperfusion followed by 0.3mg/kg/hour intravenous infusion throughout reperfusion, N = 10). Rats were also subjected to ischemia/reperfusion (I/R) and treated with saline (I/R + saline, N = 10) or with 0.3mg/kg 5-AIQ (I/R + 5-AIQ, 0.3mg/kg intravenous bolus 5 minutes prior to reperfusion followed by 0.3mg/kg/hour intravenous infusion throughout reperfusion, N = 10). Data are expressed as mean ± SE mean of N observations. ⋆P < 0.05 when compared with I/R + saline group; ▪P < 0.05 when compared sham + saline group.
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

6. Figure 5
Effect of 5-aminoisoquinolinone (5-AIQ) on creatinine clearance (glomerular filtration rate). Rats were subjected to the surgical procedure alone and treated with saline (sham + saline, N = 10) or 0.3mg/kg 5-AIQ (sham + 5-AIQ, 0.3mg/kg intravenous bolus 5 minutes prior to reperfusion followed by 0.3mg/kg/hour intravenous infusion throughout reperfusion, N = 10). Rats were also subjected to ischemia/reperfusion (I/R) and treated with saline (I/R + saline, N = 10) or with 0.3mg/kg 5-AIQ (I/R + 5-AIQ, 0.3mg/kg intravenous bolus 5 minutes prior to reperfusion followed by 0.3mg/kg/hour intravenous infusion throughout reperfusion, N = 10). Data are expressed as mean ± SE mean of N observations. ⋆P < 0.05 when compared with I/R + saline group; ▪P < 0.05 when compared sham + saline group.
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

7. Figure 6
Effect of 5-aminoisoquinolinone (5-AIQ) on alterations in FENa (tubular dysfunction). Rats were subjected to the surgical procedure alone and treated with saline (sham + saline, N = 10) or 0.3mg/kg 5-AIQ (sham + 5-AIQ, 0.3mg/kg intravenous bolus 5 minutes prior to reperfusion followed by 0.3mg/kg/hour intravenous infusion throughout reperfusion, N = 10). Rats were also subjected to ischemia/reperfusion (I/R) and treated with saline (I/R + saline, N = 10) or with 0.3mg/kg 5-AIQ (I/R + 5-AIQ, 0.3mg/kg intravenous bolus 5 minutes prior to reperfusion followed by 0.3mg/kg/hour intravenous infusion throughout reperfusion, N = 10). Data are expressed as mean±SE mean of N observations. ⋆P < 0.05 when compared with I/R + saline group; ▪P < 0.05 when compared sham + saline group.
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

8. Figure 7
Effect of 5-aminoisoquinolinone (5-AIQ) on alterations in urinary NAG levels (tubular injury). Rats were subjected to the surgical procedure alone and treated with saline (sham + saline, N = 10) or 0.3mg/kg 5-AIQ (sham + 5-AIQ, 0.3mg/kg intravenous bolus 5 minutes prior to reperfusion followed by 0.3mg/kg/hour intravenous infusion throughout reperfusion, N = 10). Rats were also subjected to ischemia/reperfusion (I/R) and treated with saline (I/R + saline, N = 10) or with 0.3mg/kg 5-AIQ (I/R + 5-AIQ, 0.3mg/kg intravenous bolus 5 minutes prior to reperfusion followed by 0.3mg/kg/hour intravenous infusion throughout reperfusion, N = 10). Data are expressed as mean ± SE mean of N observations. ⋆P < 0.05 when compared with I/R + saline group. ▪P < 0.05 when compared sham + saline group.
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

9. Figure 8
Effect of 5-aminoisoquinolinone (5-AIQ) on alterations in serum levels of aspartate aminotransferase (AST) (reperfusion-injury). Rats were subjected to the surgical procedure alone and treated with saline (sham + saline, N = 10) or 0.3mg/kg 5-AIQ (sham + 5-AIQ, 0.3mg/kg intravenous bolus 5 minutes prior to reperfusion followed by 0.3mg/kg/hour intravenous infusion throughout reperfusion, N = 10). Rats were also subjected to ischemia/reperfusion (I/R) and treated with saline (I/R + saline, N = 10) or with 0.3mg/kg 5-AIQ (I/R + 5-AIQ, 0.3mg/kg intravenous bolus 5 minutes prior to reperfusion followed by 0.3mg/kg/hour intravenous infusion throughout reperfusion, N = 10). Data are expressed as mean ± SE mean of N observations. ⋆P < 0.05 when compared with I/R + saline group. ▪P < 0.05 when compared sham + saline group.
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

10. Figure 9
Effect of 5-aminoisoquinolinone (5-AIQ) on total severity score (histologic assessment of renal injury). Rats were subjected to the surgical procedure alone and treated with saline (sham + saline, N = 6) or 0.3mg/kg 5-AIQ (sham + 5-AIQ, 0.3mg/kg intravenous bolus 5 minutes prior to reperfusion followed by 0.3mg/kg/hour intraveneous infusion throughout reperfusion, N = 6). Rats were also subjected to ischemia/reperfusion (I/R) and treated with saline (I/R + saline, N = 6) or with 0.3mg/kg 5-AIQ (I/R + 5-AIQ, 0.3mg/kg intravenous bolus 5 minutes prior to reperfusion followed by 0.3mg/kg/hour intravenous infusion throughout reperfusion, N = 6). Data are expressed as mean ± SE mean of N observations. ⋆P < 0.05 when compared with I/R + saline group; ▪P < 0.05 when compared to sham + saline group.
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

11. Figure 10
Immunohistochemical localization of PAR in sections of rat kidney; (A) sham-operated group, (B) ischemia/reperfusion (I/R)+ saline group and (C) I/R with administration of 0.3mg/kg 5-aminoisoquinolinone (5-AIQ) (0.3mg/kg intravenous bolus 5 minutes prior to reperfusion followed by 0.3mg/kg/hour intravenous infusion throughout reperfusion). Sections were incubated overnight at 4°C with primary mouse antirat monoclonal antibody directed at PAR [1:500 (vol/vol) in phosphate-buffered saline (PBS)]. Specific labeling of antigen-antibody complex was visualized using an avidin-biotin peroxidase complex immunoperoxidase technique using chromogen diaminobenzidine. Arrows indicate localization of PAR, predominantly to proximal tubular cells. Figures shown are representative of at least three experiments performed on different experimental days (magnification ×125).
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions